AlphaCT1 molecule may repair the skin's collagen matrix by altering how scar-forming cells behave

Surgical scars treated with a molecule called alphaCT1 showed a long-term improvement in appearance when compared to control scars, according to multicenter, controlled Phase II clinical trials—a finding that could help surgeons improve patient outcomes.